*Together with

Good day, 360 –

Here are our top trade ideas today – these setups look primed! Be the best prepared trader on the Street!

FRC – Up over 25% in pre-market after First Citizens takes over SVB

SI – Over 18% higher this morning after rumor Friday suggesting a crypto exchange is attempting to purchase the company’s trade processing technologies

FSR – Gapping 5% higher in pre-market after announcing the longest range of any battery electric SUV sold in Europe today

*A message from Mineral News Reports

? Hot Stock of the Day ?

I think everyone knows about the surge in gold prices lately. I mean, it is everywhere you look…

Central banks, and “mom-and-pop” investors are loading up on the shiny stuff. Who can blame investors for piling in with a looming financial crisis around the corner? ?

There is one stock out there that is focused on mining in the good ol’ US of A that SeekingAlpha called…

Interest and trading volume has been building lately, as you can imagine, but this stock is still trading for around $4 right now.

It has a pristine balance sheet with ample cash and barely any debt.

And the analysts covering the stock? They peg it over 280% higher than it currently is (and that was before the surge in gold prices this year)!

If you’re bullish on the trend for gold continuing higher, you really should check out this incredible opportunity right now.

Get started by reading the full report from our friends at Mineral News Report and do your research on this exciting stock today!

*Sponsored by Lifewater Media, please see disclosures below.

FRC – Up over 25% in pre-market after First Citizens takes over SVB

First Republic Bank (FRC) is up over 25% in the pre-market as First Citizens announced it would buy SVB. This is positive news in that now there is a blueprint for consolidation within the banking sector and banks that appeared to be in trouble such as FRC can now be given a lifeline and get bought up.

U.S authorities are also planning to give First Republic Bank more time to ramp up its balance sheet.

$15.80 was resistance in the pre-market which then became potential support. This should be an important pivot level today.

Above it, the first major target for bulls is the pre-market high of $16.80.

Beyond that, the next target to the upside is teh $19.40-$20 area with $21.59 and $24 above that.

Below $15.80 there is potential support at $15.30 and $14.50, $14 and $13.80 below that. Further targets to the downside are $13 and then a gap to fill at $12.36.

SI – Over 18% higher this morning after rumor Friday suggesting a crypto exchange is attempting to purchase the company’s trade processing technologies

Silvergate Capital (SI) closed over 50% higher on Friday after traders circulated a rumor that a crypto exchange was trying to buy the company’s trade processing technologies.

SI was gapping over 18% higher on continued strength this morning. SI is down over 95% from prices it was trading at last year after it announced that it would be liquidating its fund and winding down its assets.

$2.14 was a major resistance area on Friday and was again resistance in the pre-market this morning.

Above it, targets to the upside are $2.25, $2.50, $2.60, $3 and $3.50.

Below $2.14, there is potential support at $1.90, $1.80, a gap to fill at $1.72 with $1.60 and $1.38 as targets below that.

FSR – Gapping 5% higher in pre-market after announcing the longest range of any battery electric SUV sold in Europe today

Fisker (FSR) announced in a press release this morning that it had achieved a combined WLTP range of up to 707 km/440 UK miles for the all-electric Fisker Ocean Extreme, exceeding previous estimates. That result is the longest range of any battery electric SUV sold in Europe today.

The cutting-edge technology provides enough range in the Fisker Ocean Extreme to potentially travel from London to Glasgow or Paris to Frankfurt on a single charge. The company also stated that Fisker Centers+ locations to open across Europe and the US throughout 2023, starting on April 11th in Vienna and Copenhagen with European homologation by authorities expected by April 28, 2023, with deliveries following thereafter.

The pre-market high of $6.14 should be the first major target for bulls.

Above it, targets to the upside are $6.20, $6.47 with $7 above that.

Below $6.14 there is potential support around $6, $5.90 and then a gap to fill at $5.73. All time lows for FSR are at $5.54.

Economic Calendar (EST)

10:30am Dallas Fed MFG survey

5:00pm Fed speaker Phillip Jefferson

Earnings for Today (After Market)

BMTX, CTMX, EE, EGLX, FGI, FORA, GIPR, GROY, HOFV, KORE, LUXH, LWAY, MDWT, NOAH, NXGL, OPAL, PVH, RAIL, RGTI, RLGT, SRT, TEDU, WYY, YQ

Top Headlines

INCY Incyte Announces Japanese Approval of Pemazyre(R) (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs)

IONS Ionis reports positive topline 66-week results of eplontersen Phase 3 study for patients with ATTRv-PN

BPTS Biophytis: Biophytis Presented Sarconeos (BIO101) As A Possible Treatment Candidate for Long COVID After Hospitalization During The 13th Annual International Conference on Frailty and Sarcopenia Resea

FSR All-Electric Fisker Ocean Extreme Achieves a Combined WLTP Range of up to 707 km/440 UK Miles, the Longest Range of Any Battery Electric SUV Sold in Europe Today

UBER Uber Eats to Remove 5,000 Online-Only Menus from North American Platform – WSJ

AMZN Morgan Stanley reiterates Overweight rating, Top Pick on AMZN sees over 50% upside.

LICY Li-Cycle and KION Group Form Strategic Global Lithium-Ion Battery Recycling Partnership; Li-Cycle Announces New Spoke Development in France

RMTI Rockwell Medical to Showcase its Hemodialysis Concentrates Portfolio at DialysisTechConneXion40

YS YS Biopharma’s PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study

BCLI BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn(R) for the Treatment of ALS

AAPL Apple OLED supplier Samsung to start iPhone 15 panel production one month earlier than planned – MacRumors

PHAR wins FDA nod for rare immune disorder therapy.

BEP Brookfield and EIG Consortium Sign Binding Agreement to Acquire Origin Energy

BW: Babcock & Wilcox Solar Energy, Inc. Awarded Illinois Community Solar Installation Contracts by Summit Ridge Energy Totaling More Than $15 Million

SPIR Spire Global Awarded National Oceanographic and Oceanic Administration Contract for Satellite Weather Data

CCJ Cameco to Receive Substantial Refund of $300 Million from Canada Revenue Agency

NRXP NRx Pharmaceuticals Announces Positive Recommendation to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression

TRIB Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend – Technavio

CGEM: Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines

CYCN Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases

CDAK Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process

FOLD: Amicus Therapeutics Announces European Commission Approval for Pombiliti(TM) in Patients with Late-Onset Pompe Disease

EYPT: EyePoint Pharmaceuticals Completes Enrollment in Oversubscribed Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for Maintenance Treatment of Wet AMD

AZN Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks

TMPO: Tempo Automation Announces Definitive Agreement to Acquire Optimum Design Associates Extending Its Accelerated Manufacturing Platform to Electronic Design Services

WGO Winnebago Industries to Acquire Premier Lithium-ion Battery Solutions Provider Lithionics Battery

GMDA: Gamida Cell To Explore Strategic Options To Support A Broader Launch Of Omidubicel, Including Potential US And Global

BAND Bandwidth Announces Maestro: Connecting Best-in-Class AI and CX Capabilities for Next-Gen Enterprise Cloud Communications, With the Simplicity of Software Control

PSN Parsons Awarded $16 Million US Army Intelligence Contract

RPRX: Royalty Pharma Announces $1.0 Billion Share Repurchase Program

BIGC Mira Commerce and BigCommerce Announce Strategic Partnership to Deliver Modern Composable E-commerce Solutions

ET Energy Transfer to Acquire Lotus Midstream in a $1.45 Billion Transaction

NEGG Newegg Uses ChatGPT to Improve Online Shopping Experience

Questions or concerns about our products? Email [email protected](C) Copyright 2022, RagingBull – Refund Policy – Privacy Policy – Terms & Conditions

*PAID ADVERTISEMENT. RagingBull has been paid fourteen thousand dollars by ach bank transfer by Lifewater Media for advertising US Gold Corp. from a period beginning on March 27, 2023 through March 28 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in US Gold Corp. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of US Gold Corp., increased trading volume, and possibly an increased share price of the US Gold Corp. securities, which may or may not be temporary and decrease once the marketing arrangement has ended.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https://www.sec.gov/edgar/searchedgar/companysearch.

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.